Skip to main content

Funding round · 2026-10-16 · Healthcare

Unravel Health raises $3.2M

55
AI Score
Amount
$3.2M
Round
Undisclosed
Lead
Conduit EIS Impact Fund, Wrightwood
HQ
London, GB
Why it matters: The round shows how a saliva-based hormone reader is being funded toward early-access devices in 2027, with the same sensing technology already tested on other markers.

London-based Unravel Health raised €2.96 million led by Conduit EIS Impact Fund and Wrightwood.

Participants:
Leo Capital, Embryo Ventures, Hermesa, Zinc VC

Deal Dossier PRO

Pro feature
Deal Dossier for Unravel Health

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing